NO20054158L - Kombinert anvendelse av ribavirin og interferon beta ved demyeliserende sykdommer - Google Patents
Kombinert anvendelse av ribavirin og interferon beta ved demyeliserende sykdommerInfo
- Publication number
- NO20054158L NO20054158L NO20054158A NO20054158A NO20054158L NO 20054158 L NO20054158 L NO 20054158L NO 20054158 A NO20054158 A NO 20054158A NO 20054158 A NO20054158 A NO 20054158A NO 20054158 L NO20054158 L NO 20054158L
- Authority
- NO
- Norway
- Prior art keywords
- ribavirin
- combined use
- interferon beta
- demyelating diseases
- demyelating
- Prior art date
Links
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 title abstract 2
- 229960000329 ribavirin Drugs 0.000 title abstract 2
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 title abstract 2
- 102000003996 Interferon-beta Human genes 0.000 title 1
- 108090000467 Interferon-beta Proteins 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229960001388 interferon-beta Drugs 0.000 title 1
- 208000016192 Demyelinating disease Diseases 0.000 abstract 2
- 102000014150 Interferons Human genes 0.000 abstract 2
- 108010050904 Interferons Proteins 0.000 abstract 2
- 229940079322 interferon Drugs 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Den foreliggende oppfinnelse er i området nevrologiske hdelser. Den angår anvendelse av en forbindelse med formel (I) i kombinasjon med et interferon (IFN) til fremstilling av et legemiddel for behandling og/eller forhindring av en demyelinerende sykdom. Særlig angår den anvendelse av en kombinasjon av ribavirin og IFNbeta til behandling og/eller forhindring av en demyelinerende sykdom, så som multippel sklerose.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03100459 | 2003-02-25 | ||
PCT/EP2004/050202 WO2004075903A1 (en) | 2003-02-25 | 2004-02-24 | Combined use of ribavirin and interferon beta in demyelinating diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20054158L true NO20054158L (no) | 2005-09-07 |
Family
ID=32921601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054158A NO20054158L (no) | 2003-02-25 | 2005-09-07 | Kombinert anvendelse av ribavirin og interferon beta ved demyeliserende sykdommer |
Country Status (12)
Country | Link |
---|---|
US (1) | US20060276419A1 (no) |
EP (1) | EP1596873A1 (no) |
JP (1) | JP2006518725A (no) |
KR (1) | KR20060002758A (no) |
CN (1) | CN1761471A (no) |
AU (1) | AU2004216485B2 (no) |
BR (1) | BRPI0407781A (no) |
CA (1) | CA2515210A1 (no) |
EA (1) | EA010801B1 (no) |
MX (1) | MXPA05008998A (no) |
NO (1) | NO20054158L (no) |
WO (1) | WO2004075903A1 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2263678B1 (en) * | 2004-12-22 | 2014-06-11 | Merck Serono SA | Cladribine regimen for treating early secondary progressive Multiple Sclerosis |
US20080260690A1 (en) * | 2005-11-18 | 2008-10-23 | Ares Trading S.A. | Interferon in Influenza |
US9925151B2 (en) | 2006-05-24 | 2018-03-27 | Merck Serono Sa | Cladribine regimen for treating multiple sclerosis |
EP2076533B1 (en) | 2007-05-02 | 2014-10-08 | Ambrx, Inc. | Modified interferon beta polypeptides and their uses |
US10374993B2 (en) | 2017-02-20 | 2019-08-06 | Snap Inc. | Media item attachment system |
EA035792B1 (ru) * | 2018-06-21 | 2020-08-11 | Государственное Научное Учреждение "Институт Биоорганической Химии Национальной Академии Наук Беларуси" | Лекарственное средство пролонгированного действия для лечения рассеянного склероза (варианты) |
US11265281B1 (en) | 2020-01-28 | 2022-03-01 | Snap Inc. | Message deletion policy selection |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4307883A1 (en) * | 1992-03-12 | 1993-09-23 | Westarp Martin Egon Dr Med | Use of anti-retroviral substances - to treat motor-neuronal diseases |
EP1302474A1 (en) * | 1996-10-16 | 2003-04-16 | Ribapharm, Inc. | Monocyclic L-nucleosides, analogs and uses thereof |
AU2026900A (en) * | 1998-11-20 | 2000-06-13 | Salk Institute For Biological Studies, The | Neuron stimulation by ribavirin, and analogs thereof |
US6495677B1 (en) * | 2000-02-15 | 2002-12-17 | Kanda S. Ramasamy | Nucleoside compounds |
-
2004
- 2004-02-24 EP EP04713909A patent/EP1596873A1/en not_active Withdrawn
- 2004-02-24 US US10/546,843 patent/US20060276419A1/en not_active Abandoned
- 2004-02-24 MX MXPA05008998A patent/MXPA05008998A/es unknown
- 2004-02-24 EA EA200501344A patent/EA010801B1/ru not_active IP Right Cessation
- 2004-02-24 KR KR1020057014449A patent/KR20060002758A/ko not_active Application Discontinuation
- 2004-02-24 BR BRPI0407781-4A patent/BRPI0407781A/pt not_active IP Right Cessation
- 2004-02-24 JP JP2006502049A patent/JP2006518725A/ja active Pending
- 2004-02-24 WO PCT/EP2004/050202 patent/WO2004075903A1/en active Application Filing
- 2004-02-24 AU AU2004216485A patent/AU2004216485B2/en not_active Ceased
- 2004-02-24 CA CA002515210A patent/CA2515210A1/en not_active Withdrawn
- 2004-02-24 CN CNA2004800073990A patent/CN1761471A/zh active Pending
-
2005
- 2005-09-07 NO NO20054158A patent/NO20054158L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20060276419A1 (en) | 2006-12-07 |
KR20060002758A (ko) | 2006-01-09 |
EA200501344A1 (ru) | 2006-02-24 |
WO2004075903A1 (en) | 2004-09-10 |
JP2006518725A (ja) | 2006-08-17 |
EA010801B1 (ru) | 2008-12-30 |
EP1596873A1 (en) | 2005-11-23 |
AU2004216485B2 (en) | 2009-06-11 |
AU2004216485A1 (en) | 2004-09-10 |
MXPA05008998A (es) | 2005-10-18 |
CA2515210A1 (en) | 2004-09-10 |
BRPI0407781A (pt) | 2006-02-14 |
CN1761471A (zh) | 2006-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054158L (no) | Kombinert anvendelse av ribavirin og interferon beta ved demyeliserende sykdommer | |
WO2006122011A3 (en) | Thiazole compounds and methods of use | |
WO2005007681A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
WO2006039488A3 (en) | Hcv ns3-ns4a protease inhibition | |
WO2005037860A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
MXPA05005379A (es) | Tioureas de arilo sustituidas y compuestos relacionados; inhibidores de duplicacion viral. | |
WO2005067900A3 (en) | Azabenzofuran substituted thioureas as inhibitors of viral replication | |
EA200300776A1 (ru) | Производные фенэтаноламина для лечения респираторных заболеваний | |
UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
EA200701296A1 (ru) | 3,5-дизамещенные и 3,5,7-тризамещенные 3h-оксазоло- и 3h-тиазоло[4,5-d] пиримидин-2-оны и их пролекарства | |
TW200600492A (en) | Substituted aryl acylthioureas and related compounds; inhibitors of viral replication | |
EP2311851A3 (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | |
MY148123A (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
ATE465164T1 (de) | Triazolopyrazinverbindungen zur behandlung von degenerations- und entzündungskrankheiten | |
WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
WO2005095345A3 (en) | Heteroaryl guanidines as inhibitors of viral replication | |
EA200601846A1 (ru) | Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей | |
WO2007014943A3 (en) | Therapy for neurological diseases | |
TNSN06403A1 (en) | 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF | |
WO2005037798A3 (en) | Amide or thiomide derivatives and their use in the treatment of pain | |
GB0130677D0 (en) | Medicaments and novel compounds | |
HK1079526A1 (en) | A novel pyrazine compound and its use in the manufacture of a medicament for treating diseases related to serotonin | |
EA200701615A1 (ru) | Новые лекарственные средства для лечения заболеваний дыхательных путей | |
DE602004014728D1 (de) | Behandlung von durch das ljungan-virus ausgelösten erkrankungen durch verwendung von pleconaril | |
MY143775A (en) | Compound having anti-hcv action |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |